MOL #33761

Introduction
Adrenomedullin (ADM), a 52 amino-acid peptide, was first isolated from human pheochromocytoma in 1993 (Kitamura et al., 1993) . ADM in peripheral tissues plays important roles in regulating vascular tone, cardiac output and renal functions, and systemic infusion of ADM has therapeutic effects on hypertension, myocardial infarction, and heart and renal failure (Ishimitsu et al., 2006) . In addition to its actions in the periphery, ADM contributes extensively to the maintenance of homeostasis through central mechanisms. Thus, centrally-administrated ADM inhibits thirst and salt appetite (Taylor et al., 2005) , suppresses food intake (Taylor et al., 1996) , and regulates blood pressure, heart rate and baroreflex sensitivity by modulating autonomic activity (Shan and Krukoff, 2001; Xu and Krukoff, 2004a; Xu and Krukoff, 2004b; Xu and Krukoff, 2006) .
Although the molecular mechanisms for ADM's actions in the brain remain unclear, evidence from our laboratory suggests that nitric oxide (NO), a non-conventional neurotransmitter in the central nervous system (Krukoff, 1999) , is an important mediator of ADM's actions in the brain. For example, ADM activates NO-producing neurons in the hypothalamic paraventricular nucleus (PVN) and stimulates NO production in the hypothalamus (Shan and Krukoff, 2001 ). In addition, the hypotensive effects induced by microinjections of ADM into the PVN are attenuated by inhibition of NO synthesis (Xu and Krukoff, 2004b) . Similarly, the NO-cyclic GMP cascade mediates ADM's This article has not been copyedited and formatted. The final version may differ from this version.
Molecular Pharmacology Fast Forward. Published on April 19, 2007 as DOI: 10.1124 at ASPET Journals on June 21, 2017 molpharm.aspetjournals.org Downloaded from hypertensive effects in the rostral ventrolateral medulla, an autonomic center in the brainstem that participates in maintaining sympathetic tone (Xu and Krukoff, 2004a) .
Finally, we demonstrated a direct stimulatory effect of ADM on NO production in SK-N-SH human neuroblastoma cells in vitro (Xu and Krukoff, 2005) . However, the mechanisms by which ADM stimulates NO production in primary neurons remain to be identified.
NO production in neurons is catalyzed by neuronal nitric oxide synthase (nNOS) and multiple mechanisms are involved in the regulation of nNOS activity. A transient rise in [Ca 2+ ] i leads to formation of the Ca 2+ -calmodullin complex (Ca 2+ -CaM) which, in turn, binds to and activates nNOS by regulating inter-subunit electron transfer and oxygen activation (Panda et al., 2001 ). In addition, nNOS is phosphorylated and therefore regulated by various kinases, including protein kinase A (PKA), protein kinase C (PKC), cyclic GMP-dependent kinase, and calmodulin-dependent kinase II (CaMKII) (Bredt et al., 1992; Dinerman et al., 1994; Komeima et al., 2000) . In particular, phosphorylation of nNOS at serine 847 suppresses the binding of nNOS with Ca 2+ -CaM and decreases the catalytic activity of the enzyme (Komeima et al., 2000) . On the other hand, protein phosphatases, such as protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A), and calcineurin (also known as protein phosphatase 2B), reverse this inhibitory phosphorylation and stimulate nNOS activity (Rameau et al., 2003) .
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In the present study, primary rat hypothalamic neurons were used as a model to investigate the mechanisms by which ADM stimulates NO production in neurons.
Expression of ADM receptor components, calcitonin receptor-like receptor (CRLR) and receptor-activity-modifying protein 2 or 3 (RAMP-2/3) (McLatchie et al., 1998) 
Methods
Cell Culture
Primary hypothalamic neurons were cultured using a modified protocol based on a previous study (Boyadjieva et al., 2003) . Briefly, in a sterile environment, pregnant
Sprague-Dawley rats on days 17-18 of gestation were anesthetized with Halothane (Halocarbon Laboratories, River Edge, NJ), embryos were surgically removed from the mothers, and brains were removed from the embryos. Hypothalami were dissected anteriorly, ~1 mm rostral to the optic chiasm; posteriorly, at the rostral extent of the mammillary bodies; and laterally, at the hypothalamic sulci. The depth of the excised tissue was approximately 2 mm. The hypothalami were dissected in Hank's balanced salt solution supplemented with 15 mM HEPES, 10 U/mL penicillin and 10 mg/mL streptomycin, digested with 0.05% trypsin for 15 min, triturated and then plated in 6 or 96-well culture plates, or 12 or 40-mm-diameter coverslips coated with 10 mg/mL poly-D-lysine (Sigma-Aldrich). The cultures were grown at 37°C in a 5% CO 2 humidified atmosphere and the medium was changed every 2 days. Neurobasal medium supplemented with 10% fetal bovine serum, N2 supplement, 15 mM HEPES, 1.5 mM sodium pyruvate, 30 U/mL penicillin, 30 µ g/mL streptomycin and 0.6 mM glutamine was used as culture medium for the first 2 days; on the third day, glutamine was substituted by 10 nM cytosine arabinoside (Sigma-Aldrich). On day 5, fetal bovine serum was removed from the culture medium. All reagents for cell culture, except when otherwise mentioned, were purchased from GIBCO (Burlington, ON, Canada). Using antibodies for MOL #33761 microtubule-associated protein-2 (GeneTex, San Antonio, TX) and for glial fibrillary acidic protein (Santa Cruz Biotechnology, Santa Cruz, CA), we determined that, in 10-day cultures, about 90% of cells are neurons and about 1% of the population is composed of astrocytes. Thus, experiments described below were performed with cells from day 10 or day 11 cultures.
Immunocytochemistry
Cells cultured on 12-mm-diameter coverslips (2 × 10 5 cells/coverslip) were fixed with 3% paraformaldehyde for 20 min and air-dried. The coverslips were then incubated in 0.1% Triton X-100 in PBS for 4 min, followed by 3 washes with 0.2% gelatin (Fisher Scientific, Nepean, Ontario, Canada) in PBS. The coverslips were incubated with 1:500 goat anti-CRLR (Santa Cruz) together with 1:500 rabbit anti-RAMP-2 (Santa Cruz), 1:500 rabbit anti-RAMP-3 (Santa Cruz) or 1:500 rabbit anti-nNOS (Santa Cruz) for 1. This article has not been copyedited and formatted. The final version may differ from this version. (Rameau et al., 2003) , 1 µ M FK506 (Tacrolimus, a calcineurin inhibitor; Sigma-Aldrich) (Rameau et al., 2003) or cyclosporine A (CsA, a calcineurin inhibitor; Sigma-Aldrich) (Rameau et al., 2003) , were used to evaluate the contributions of nNOS, Ca 2+ , PKA and protein phosphatases, respectively, in the ADM-induced responses. In control experiments, MEM was injected into the chamber at corresponding time points. Fluorescence intensity from each cell was quantified over time using LSM 510 software (EMBL), and relative [Ca 2+ ] i
This article has not been copyedited and formatted. The final version may differ from this version. and NO levels were represented as the ratios of fluorescence intensities to their respective basal levels (F/F 0 ).
Measurement of Intracellular cAMP by EIA
As described previously (Xu and Krukoff, 2005) , cells (grown at a density of 10 5 /well in 96-well culture plates) were treated with 0.5 mM IBMX (1-Methyl-3-isobutylxanthine, a cyclic nucleotide phosphodiesterase inhibitor; Sigma-Aldrich) for 30 min to prevent breakdown of accumulated cAMP, followed by treatment with vehicle, 1 nM or 10 nM ADM for 5 min. Intracellular cAMP levels were measured with a commercial enzyme immunoassay kit according to the manufacturer's instructions (Amersham).
Phosphorylation of nNOS analyzed with Western blotting
To illustrate the dose response of the ADM-induced nNOS dephosphorylation in hypothalamic neurons, cells cultured in 6-well plates (1-2 × 10 6 cells/well) were treated with MEM, 0.1 nM ADM, 1 nM ADM, or 10 nM ADM for 300 sec (5 min). In time-course experiments, the cells were incubated with 10 nM ADM for 0, 50, 100, and 300 sec. To determine the mechanisms of the ADM-induced nNOS dephosphorylation, the cells were pretreated with MEM, 0.1 . The same membranes were stripped and probed with 1:500 rabbit anti-nNOS antibody (Santa Cruz) or 1:4000 mouse anti-β-actin antibody (Sigma-Aldrich), and densities of total nNOS and β -actin bands were measured as described above. The levels of nNOS were calculated as the ratio of nNOS/β-actin and normalized to results in MEM treatment, whereas the levels of phosphorylated nNOS Ser 847 are presented as the ratio of phospho-nNOS ser847 /nNOS and normalized to results in MEM treatment.
Statistical analysis
Data were presented as mean values ± SEM. Statistical analyses were carried out with
SigmaStat software. Depending on the experiments, differences among groups were determined by one-way or two-way ANOVA analysis, followed by the post-hoc This article has not been copyedited and formatted. The final version may differ from this version. 
Results
Expression of CRLR, RAMP-2/3 and nNOS in hypothalamic neurons
Using double-labeling immunocytochemistry, we found that about 20% of cells in the cultures co-expressed the ADM receptor components, CRLR and RAMP-2/RAMP-3 (Figs. 1A and 1B). In addition, colocalization of CRLR with RAMP-2/RAMP-3 was found in the soma, neurites, and more importantly, cell membrane, which suggests that functional ADM receptors are present in these cells.
The majority of CRLR-positive cells also expressed nNOS (Fig. 1C) , indicating that these putative ADM-responsive cells have the ability to produce NO. We also found that a proportion of nNOS was colocalized with CRLR on the membrane. Since similar colocalization of nNOS and the N-methyl-D-aspartate (NMDA) receptor has been considered to ensure rapid nNOS activation following NMDA stimulation (Aoki et al., 1997) , the observed proximity of nNOS and ADM receptor may also provide the morphological basis for the functional interaction between ADM and nNOS.
ADM increases [Ca
2+
] i and NO production in receptor-and nNOS-dependent manners with increased NO production. Results described below were obtained from these ADM-responsive neurons. decreases in Calcium Orange-generated fluorescence were observed when MEM was injected into the chamber at the corresponding time points, whereas DAF-FM-generated fluorescence gradually decreased over time by no more than 16% of the basal levels ( Fig.   2C ), presumably due to photo-bleaching.
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On the other hand, the ADM-induced increases in [Ca 2+ ] i and NO production in 5 cells
were not affected by CGRP 8-37 (Fig. 3B) . Since the ADM receptor, comprised of CRLR and RAMP-2, is more sensitive to ADM 22-52 , whereas the CRLR-RAMP-3 receptor complex shows a clear preference for CGRP 8-37 -induced antagonism (Hay et al., 2004) , these results suggest that the CRLR-RAMP-2 receptor complex plays the predominant role in mediating ADM's effects in the hypothalamic neurons.
In 7 cells, ADM-stimulated NO production was completely blocked with the selective nNOS inhibitor, vinyl-L-NIO (2 µ M) (Fig. 4A) , demonstrating that activation of nNOS is responsible for the ADM-stimulated NO production. Vinyl-L-NIO itself decreased resting levels of NO production to 48±10%, which suggests that basal NO production in the hypothalamic neurons is also dependent on activity of nNOS. (Fig. 4B) , respectively, suggesting that basal NO production in these cells is also a Ca 2+ -dependent event.
The cAMP-PKA pathway mediates ADM-stimulated Ca 2+ and NO responses
To determine whether ADM stimulates increases in [Ca 2+ ] i and NO production via the cAMP-PKA pathway, we first evaluated the effects of ADM on cAMP levels. Figure 5A shows that treatment with ADM at 1 nM or 10 nM for 5 min significantly increased intracellular cAMP levels compared to controls (vehicle treatment), and that the effect of 10 nM ADM was significantly higher than that of 1 nM ADM. (Fig. 5B) .
nNOS dephosphorylation contributes to ADM-stimulated NO production
This article has not been copyedited and formatted. The final version may differ from this version. Because phosphorylation of nNOS at serine 847 has been shown to exert an inhibitory effect on the activity of nNOS (Komeima et al., 2000) , we investigated whether ADM modulates this phosphorylation. ADM application (10 nM, 5 min) significantly decreased nNOS phosphorylation at serine 847 by 57±14%, whereas total nNOS levels remained unchanged (Figs. 6A and 6B ). Lower doses of ADM (0.1 nM and 1 nM, 5 min) also appeared to dephosphorylate nNOS, but these responses were not statistically significant (Figs. 6A and 6B). Finally, ADM induced nNOS dephosphorylation in a time-dependent manner so that 10 nM ADM significantly decreased nNOS phosphorylation by 38±14%
and 57±13% at 100 and 300 sec, respectively, while 50 sec after ADM treatment, the phosphorylation levels of nNOS were comparable to the basal levels ( Figs. 6C and 6D ).
PP1/PP2A and calcineurin have been shown to mediate NMDA-induced nNOS dephosphorylation at serine 847 in cortical neurons (Rameau et al., 2003) . Therefore, we asked whether PP1/PP2A and calcineurin are responsible for the ADM-induced nNOS dephosphorylation. Pretreatment with OA (0.1 µM, 10 min), a PP1/PP2A inhibitor, abrogated the decrease in nNOS phosphorylation induced by ADM (10 nM, 5 min).
Similar inhibition of nNOS dephosphorylation was observed when the cells were pretreated with calcineurin inhibitors, FK506 (1 µM, 10 min) or CsA (0.1 µM, 10 min) ( Fig. 7A and 7B ). Thus, these data indicate that both PP1/PP2A and calcineurin are recruited by ADM to dephosphorylate nNOS.
This article has not been copyedited and formatted. The final version may differ from this version. are involved in the ADM-induced NO production. Treatments with OA, FK506, or CsA alone decreased the basal NO production levels to 68±10%, 84±10% or 75±5%, respectively, suggesting that PP1/PP2A and calcineurin also contribute to the maintenance of basal nNOS activity in hypothalamic neurons.
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Discussion
We demonstrate in this study that ADM rapidly stimulates an increase in NO production in cultured hypothalamic neurons and that this effect occurs in a Ca 2+ -dependent manner.
In addition, we suggest that nNOS dephosphorylation by protein phosphatases mediates ADM-stimulated increases in NO production. Finally, our data show that the cAMP-PKA pathway mediates the NO response by regulating intracellular Ca 2+ dynamics and nNOS phosphorylation.
In vivo evidence suggests that ADM stimulates NO production in neurons. For example, the ADM receptor component, RAMP-2, is expressed in nNOS-positive neurons (Xu and Krukoff, 2004b) and peripheral or central administration of ADM activates nNOS-positive neurons in the brain (Shan and Krukoff, 2000; Shan and Krukoff, 2001 ).
Consistent with these findings, we now show that ADM stimulates a rapid and nNOS-mediated NO synthesis in cultured primary neurons in a receptor-dependent manner. Increased NO synthesis in neurons is important for the physiological actions of ADM in the brain as central NO mediates ADM's effects on blood pressure regulation, demonstrated by our previous observations that alterations in blood pressure and heart rate induced by ADM in the PVN or rostral ventrolateral medulla are attenuated or abolished by NOS inhibitors (Xu and Krukoff, 2004a; Xu and Krukoff, 2004b) . Increased NO production may also play a role in the regulatory effects of ADM on hypothalamic vasopressin secretion and body fluid homeostasis (Taylor et al., 2005) . Supporting this This article has not been copyedited and formatted. The final version may differ from this version. suggestion, intracerebroventricular ADM administration activates nNOS-positive neurons in the magnocellular subdivision of the PVN (Shan and Krukoff, 2001) where vasopressin is produced. In addition, ADM has been shown to protect neurons from ischemia, and this effect is associated with elevated NO levels (Xia et al., 2006) .
In an attempt to identify mechanisms by which ADM activates nNOS and stimulates NO production, we investigated the involvement of three distinct but related signaling pathways: protein phosphatases, Ca 2+ signaling, and the cAMP-PKA pathway. First, ADM is shown to concentration-and time-dependently induce dephosphorylation of nNOS at serine 847 via activities of PP1/PP2A and calcineurin. Our finding that inhibition of these phosphatases significantly attenuates NO synthesis suggests that this nNOS dephosphorylation contributes to ADM-induced NO production. The role of these phosphatases to mediate NMDA-induced nNOS dephosphorylation at serine 847 and elevated NO production has also been demonstrated in rat cortical neurons (Rameau et al., 2003) .
It has been well established that elevations in [Ca 2+ ] i lead to activation of nNOS by inducing the interaction of calmodulin (CaM) and nNOS (Panda et al., 2001) . We confirm that an increase in [Ca 2+ ] i is required for the ADM-stimulated NO production in hypothalamic neurons since ADM simultaneously increases [Ca 2+ ] i and NO production and ADM-stimulated NO production is abolished when cytosolic free is chelated with This article has not been copyedited and formatted. The final version may differ from this version. ] i is necessary for the initial activation of nNOS, the maintenance of nNOS activity may be Ca 2+ -independent. In support of this idea, it has been shown in vitro that a transient increase in [Ca 2+ ] i in endothelial cells is associated with a sustained interaction of CaM and eNOS, another Ca 2+ -CaM-dependent isoform of NOS (Jobin et al., 2003) .
Besides facilitating the interaction of CaM and nNOS, concentrated Ca 2+ may also activate nNOS, at least in part, by dephosphorylating the enzyme, based on the observation that chelation of cytosolic free Ca 2+ blunts ADM-induced nNOS dephosphorylation. ADM-stimulated Ca 2+ accumulation likely leads to activation of calcineurin (Shou et al., 2004 ) which, in turn, dephosphorylates nNOS. Interestingly, we also found that application of BAPTA-AM alone significantly decreases nNOS phosphorylation in the resting state. We believe that this response can be attributed to the inhibition of CaMKII evoked by Ca 2+ chelation, given that CaMKII is involved in the constitutive phosphorylation of nNOS (Komeima et al., 2000) .
The cAMP-PKA pathway is coupled to ADM receptors in various types of cells (Kitamura et al., 1993; Shimekake et al., 1995) , including neural cells (Xu and Krukoff, 2005) . In addition, PKA mediates nNOS activation induced by diverse stimuli, such as electrical field stimulation (Ferrer et al., 2004) , and application of endothelin This article has not been copyedited and formatted. The final version may differ from this version. (Jaureguiberry et al., 2004) or β -adrenoceptor agonists (Birder et al., 2002 reported in urothelial cells (Birder et al., 2002) , enterocytes (Canani et al., 2003) and neuroblastoma cells (Xu and Krukoff, 2005) . Alternatively but not exclusively, PKA may stimulate nNOS activation by activating protein phosphatases to remove the inhibitory serine 847 phosphorylation from nNOS. The involvement of the PKA-phosphatase-NO cascade is supported by the observation that H-89 abolishes the ADM-induced nNOS dephosphorylation. PKA may activate phosphatases through multiple signal cascades. For example, PKA may indirectly activate PP1, since PKA has been shown to suppress activities of endogenous PP1 inhibitors such as the nuclear inhibitor of PP1 (Beullens et al., 1993) and gastrointestinal-and brain-specific PP1-inhibitory protein (Liu et al., 2004) . PKA may also activate calcineurin via a Ca 2+ -dependent mechanism given that PKA stimulates intracellular accumulation of Ca 2+ , as discussed above.
This article has not been copyedited and formatted. The final version may differ from this version. Indeed, H-89-stimulated Ca 2+ accumulation has been reported to occur in muscle cells (Lahouratate et al., 1997) , lymphocytes (de la Rosa et al., 2001 ) and neuroblastoma cells (Xu and Krukoff, 2005) , and is presumably due to nonspecific effects of H-89 on the endoplasmic reticulum-associated Ca 2+ ATPase (de la Rosa et al., 2001 ).
H-89 itself also decreases nNOS phosphorylation in the resting state, consistent with previous studies which suggest that PKA contributes to the constitutive phosphorylation of nNOS (Bredt et al., 1992; Dinerman et al., 1994) . It is intriguing, however, that H-89 alone induces both an increase in [Ca 2+ ] i and a decrease in nNOS phosphorylation, and that these processes are not accompanied by increased NO production. We interpret these results to suggest that nonspecific H-89-induced intracellular Ca 2+ accumulation occurs at a site distant from nNOS so that the increase in [Ca 2+ ] i is not sufficient to activate nNOS.
In fact, it has been suggested that the proximity of nNOS and Ca 2+ is essential for activation of the enzyme (Kone et al., 2003) . Alternatively, these data may also suggest that elevations in [Ca 2+ ] i and nNOS dephosphorylation are required but not sufficient to induce nNOS activation and NO production, and that other unknown PKA-dependent mechanisms are required for these processes. For instance, it has been demonstrated that NOS-interaction protein (NOSIP), interacts with and inhibits nNOS (Dreyer et al., 2004) .
This article has not been copyedited and formatted. The final version may differ from this version. PKA/Ca 2+ -associated pathways lead to PP1/PP2A-and calcineurin-mediated dephosphorylation of nNOS. According to our model, both of these processes may finally contribute to activation of nNOS and production of NO. These data not only provide important in vitro evidence supporting the notion that NO mediates at least some of ADM's actions in the brain, they also contribute to the fundamental understanding about ADM-initiated signaling in neurons.
